Our blogs

Research

Latest

Joshs 100 miles for Liam

To help Liam reach his target for his life saving vaccine

Andrea’s B-Day fundraiser for Liam Scott

I would like see Liam get the treatment he needs❤️

I want Liam to live a life of good health like most 4 year olds. I want him to be free of his suffering and for his family to have all of this behind them and to be happy together with Liam back to good health.

Charities fund new clinical trial

Solving Kids’ Cancer, with Neuroblastoma UK, has awarded a grant of £609,762.40 to enable the SIOPEN High-Risk Neuroblastoma Clinical Trial 2 (HR-NBL2) to open in the UK, it is anticipated to open in early 2021.

Lily-Mae, Ireland’s Tiny Dancer, supports Solving Kids’ Cancer

Lily-Mae from Galway, Ireland will be celebrating her 12th birthday this April, but for her parents Judith and Leighton every day is a blessing.

Corey is thriving after neuroblastoma battle

Family donate almost £150,000 to neuroblastoma research

BEACON study opens in Europe

The much-anticipated BEACON study amendment is now open and recruiting patients.

Steve Richards to step down as Chief Executive

CEO to leave Solving Kids' Cancer after three years in the role.

Solving Kids’ Cancer appoints new Chief Executive Officer

Solving Kids’ Cancer, a national neuroblastoma charity, has appointed Gail Jackson as its new Chief Executive Officer.

Charities fund new clinical trial

Ewen's Urgent Appeal

Ewen is a happy and restless boy who runs everywhere. He loves trucks, cars and blowing dandelions. But this amazing little boy has had his childhood interrupted by childhood cancer.

Liam's Appeal

Liam has high-risk neuroblastoma and his family are appealing for your help to raise £232,000.

PUBLIC UPDATE ON COVID-19 FROM NEUROBLASTOMA UK AND SOLVING KIDS' CANCER

Joint statement from Solving Kids' Cancer and Neuroblastoma UK on COVID-19 (coronavirus). 17th March 2020

Maya’s Appeal

Maya is accessing the Bivalent Vaccine in New York but still desperately needs your help to raise the funds to finish it.